[Levamethadone as substitution treatment of opioid-dependent patients].
Institut für Klinische Pharmakologie, Forschungsverbund Public Health Sachsen und Sachsen-Anhalt, Technische Universität Dresden.
E A
EA
Mueller
W
W
Kirch
D000701:Analgesics, Opioid / Q000627:therapeutic use; D015897:Comorbidity; D064420:Drug-Related Side Effects and Adverse Reactions / Q000401:mortality* / Q000517:prevention & control*; D005858:Germany / Q000453:epidemiology; D008691:Methadone / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment / Q000401:mortality*; D009293:Opioid-Related Disorders / Q000401:mortality*; D015995:Prevalence; D018570:Risk Assessment; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D008691:Methadone